ENTA · Company research
Enanta Pharmaceuticals, Inc (ENTA): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 12.37 | $366,339,600 | 331411600.000 | 34.7222222222222222 | — | — | 21.3497056938050003 | 3.1072588169434596 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.